Restart Life Sciences Corp. is a biotechnology company, which engages in the research and development of psilocybin. It offers therapy and diagnostics for neuroinflammatory disorders. company was founded on October 27, 2004 and is headquartered in Vancouver, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company